{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:46:04Z","timestamp":1791909964217,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"University of Warmia and Mazury","award":["15.610.008-300"],"award-info":[{"award-number":["15.610.008-300"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.intimp.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:17:39Z","timestamp":1508113059000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Inhaled glucocorticoid treatment prevents the response of CD8+ T cells in a mouse model of allergic asthma and causes their depletion outside the respiratory system"],"prefix":"10.1016","volume":"53","author":[{"given":"Monika","family":"Zu\u015bka-Prot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Ma\u015blanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2017.10.012_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.intimp.2017.02.005","article-title":"Effect of inhaled and systemic glucocorticoid treatment on CD4+ regulatory and effector T cells in a mouse model of allergic asthma","volume":"45","author":"Zu\u015bka-Prot","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8+ T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2017.10.012_bb0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0091-6749(97)70252-5","article-title":"Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma","volume":"100","author":"Majori","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0020","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.118.4.1042","article-title":"Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers","volume":"118","author":"Sharma","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2017.10.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.2.e24","article-title":"Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy","volume":"109","author":"Gemou-Engesaeth","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.intimp.2017.10.012_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1398-9995.1999.00747.x","article-title":"The effect of intranasal and inhaled corticosteroids in healthy volunteers on the number of circulating lymphocytes and lymphocyte subsets","volume":"54","author":"Fokkens","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2017.10.012_bb0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.2006.02592.x","article-title":"Effects of inhaled ciclesonide on circulating T-helper type 1\/T-helper type 2 cells in atopic asthmatics after allergen challenge","volume":"36","author":"Kawayama","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2017.10.012_bb0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1034\/j.1399-3038.2001.012004194.x","article-title":"Increased bronchoalveolar lavage CD8 lymphocyte subset population in wheezy infants","volume":"12","author":"Arnoux","year":"2001","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0045","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/ajrccm.164.4.2102018","article-title":"Activated, cytotoxic CD8+ T lymphocytes contribute to the pathology of asthma death","volume":"164","author":"O'Sullivan","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2017.10.012_bb0050","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/eji.200425715","article-title":"CD8+ T cell contributions to allergen induced pulmonary inflammation and airway hyperreactivity","volume":"35","author":"Schaller","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1164\/rccm.200504-619OC","article-title":"Bronchial CD8 cell infiltrate and lung function decline in asthma","volume":"172","author":"van Rensen","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2017.10.012_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/13993003.01525-2015","article-title":"Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells","volume":"48","author":"den Otter","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2017.10.012_bb0065","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/eji.200324623","article-title":"CD8+ T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation","volume":"34","author":"Stock","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0070","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaci.2008.08.011","article-title":"Innate responsiveness of CD8 memory T-cell populations nonspecifically inhibits allergic sensitization","volume":"122","author":"Leggat","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/rccm.200902-0190OC","article-title":"Specific CD8 T cells in IgE-mediated allergy correlate with allergen dose and allergic phenotype","volume":"181","author":"Aguilar-Pimentel","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2017.10.012_bb0080","first-page":"211","article-title":"Low frequency of CD8+CD25+FOXP3BRIGHT T cells and FOXP3 mRNA expression in the peripheral blood of allergic asthma patients","volume":"26","author":"Eusebio","year":"2012","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.intimp.2017.10.012_bb0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/0394632015584508","article-title":"The relative values of CD8+CD25+Foxp3brigh Treg cells correlate with selected lung function parameters in asthma","volume":"28","author":"Eusebio","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0090","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jaci.2004.07.014","article-title":"Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma","volume":"114","author":"Karagiannidis","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0404.2008.01090.x","article-title":"Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis","volume":"119","author":"Braitch","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.intimp.2017.10.012_bb0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1398-9995.2009.02056.x","article-title":"Decreased FOXP3 protein expression in patients with asthma","volume":"64","author":"Provoost","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2017.10.012_bb0105","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/S0021-9258(18)49895-X","article-title":"The interleukin-2 receptor","volume":"266","author":"Waldmann","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2017.10.012_bb0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.humimm.2008.08.288","article-title":"Murine CD8+ regulatory T lymphocytes: the new era","volume":"69","author":"Pomi\u00e9","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humimm.2008.08.283","article-title":"Inhibitory CD8+ T cells in autoimmune disease","volume":"69","author":"Suzuki","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy","volume":"6","author":"Churlaud","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2016.02.023","article-title":"I\u03baB kinase \u03b2 inhibitor, IMD-0354, prevents allergic asthma in a mouse model through inhibition of CD4+ effector T cell responses in the lung-draining mediastinal lymph nodes","volume":"775","author":"Ma\u015blanka","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2017.10.012_bb0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.rvsc.2012.12.005","article-title":"Effects of dexamethasone and meloxicam on bovine CD25+CD8+ and CD25\u2212CD8+ T cells \u2013 in vitro study","volume":"94","author":"Ma\u015blanka","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.intimp.2017.10.012_bb0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(00)02581-2","article-title":"Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study","volume":"356","author":"Brutsche","year":"2000","journal-title":"Lancet"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917303818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576917303818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:50:02Z","timestamp":1791906602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576917303818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":27,"alternative-id":["S1567576917303818"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2017.10.012","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled glucocorticoid treatment prevents the response of CD8+ T cells in a mouse model of allergic asthma and causes their depletion outside the respiratory system","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}